scholarly article | Q13442814 |
P50 | author | Yoram Cohen | Q39063399 |
Mohammad Obaidul Hoque | Q58472169 | ||
Anirban Maitra | Q63019787 | ||
Michael Goggins | Q63021511 | ||
Noriyoshi Fukushima | Q91795800 | ||
Joseph A Califano | Q98733558 | ||
David Sidransky | Q106888457 | ||
Elizabeth Mambo | Q114442434 | ||
P2093 | author name string | Aravinda Chakravarti | |
Nila Shah | |||
Susannah E D Gillespie | |||
P2860 | cites work | Light-generated oligonucleotide arrays for rapid DNA sequence analysis | Q24563041 |
High-throughput variation detection and genotyping using microarrays | Q24617968 | ||
Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array | Q24648335 | ||
Base-calling of automated sequencer traces using phred. II. Error probabilities | Q27860615 | ||
Base-calling of automated sequencer traces using phred. I. Accuracy assessment | Q27860665 | ||
Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA | Q27860870 | ||
Facile detection of mitochondrial DNA mutations in tumors and bodily fluids | Q28138849 | ||
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer | Q28289377 | ||
High density synthetic oligonucleotide arrays | Q29616560 | ||
PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing | Q29618564 | ||
Molecular profiling of human cancer | Q30659943 | ||
Use of proteomic patterns in serum to identify ovarian cancer | Q30819686 | ||
Extensive somatic mitochondrial mutations in primary prostate cancer using laser capture microdissection | Q30870711 | ||
Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology | Q30980947 | ||
High-performance genetic analysis using microfabricated capillary array electrophoresis microplates | Q31028997 | ||
Cancer statistics, 2000. | Q33895772 | ||
Mitochondrial genome instability in human cancers | Q34164887 | ||
Somatic mutations of the mitochondrial genome in human colorectal tumours | Q34478926 | ||
Mitochondrial DNA alterations in cancer. | Q34718441 | ||
Light-directed, spatially addressable parallel chemical synthesis | Q35012280 | ||
Rapid screening mitochondrial DNA mutation by using denaturing high-performance liquid chromatography | Q36308510 | ||
Strategies for mutational analysis of the large multiexon ATM gene using high-density oligonucleotide arrays | Q38330003 | ||
Detecting colorectal cancer in stool with the use of multiple genetic targets | Q39569642 | ||
Detection of APC mutations in fecal DNA from patients with colorectal tumors | Q39592582 | ||
Resequencing and mutational analysis using oligonucleotide microarrays | Q40827778 | ||
Comparison of TP53 mutations identified by oligonucleotide microarray and conventional DNA sequence analysis | Q41737680 | ||
Evaluation of the performance of a p53 sequencing microarray chip using 140 previously sequenced bladder tumor samples. | Q51603995 | ||
Detection of mitochondrial DNA mutations in pancreatic cancer offers a "mass"-ive advantage over detection of nuclear DNA mutations. | Q52067109 | ||
Accessing genetic information with high-density DNA arrays. | Q52293633 | ||
Mitochondrial C-tract alteration in premalignant lesions of the head and neck: a marker for progression and clonal proliferation. | Q53388599 | ||
Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors | Q57240044 | ||
Mitochondrial mutations in early stage prostate cancer and bodily fluids | Q62523597 | ||
Molecular detection of primary bladder cancer by microsatellite analysis | Q70923967 | ||
Mitochondrial DNA alterations in thyroid cancer | Q73083509 | ||
Mitochondrial gene mutation, but not large-scale deletion, is a feature of colorectal carcinomas with mitochondrial microsatellite instability | Q73083931 | ||
Microsatellite instability and mutation of mitochondrial and nuclear DNA in gastric carcinoma | Q73719421 | ||
Nuclear and mitochondrial genome instability in human breast cancer | Q74181156 | ||
Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates | Q74631084 | ||
Detection of mitochondrial DNA alterations in the serum of hepatocellular carcinoma patients | Q74787904 | ||
Detection of mitochondrial DNA alterations in primary tumors and corresponding serum of colorectal cancer patients | Q77357632 | ||
Mitochondrial D-loop mutations as clonal markers in multicentric hepatocellular carcinoma and plasma | Q77626777 | ||
P433 | issue | 5 | |
P921 | main subject | high-throughput sequencing | Q112147935 |
P304 | page(s) | 812-819 | |
P577 | publication date | 2004-05-01 | |
P1433 | published in | Genome Research | Q5533485 |
P1476 | title | The Human MitoChip: a high-throughput sequencing microarray for mitochondrial mutation detection | |
P478 | volume | 14 |
Q36099019 | A Cost-Effective Approach to Sequence Hundreds of Complete Mitochondrial Genomes |
Q57161603 | A DNA resequencing array for pathogenic mutation detection in hypertrophic cardiomyopathy |
Q36328949 | A bioinformatic filter for improved base-call accuracy and polymorphism detection using the Affymetrix GeneChip whole-genome resequencing platform |
Q36683816 | A focused microarray to study human mitochondrial and nuclear gene expression. |
Q54623162 | A microarray system for genotyping 150 single nucleotide polymorphisms in the coding region of human mitochondrial DNA. |
Q33254469 | A molecular scheme for improved characterization of human embryonic stem cell lines |
Q50526524 | A new mitochondria-related disease showing myopathy with episodic hyper-creatine kinase-emia. |
Q40139889 | A panel of tests to standardize the characterization of human embryonic stem cells |
Q36411661 | Affymetrix GeneChip system: moving from research to the clinic |
Q37724464 | An equipment-free polydimethylsiloxane microfluidic spotter for fabrication of microarrays |
Q35790280 | An oligonucleotide microarray for high-throughput sequencing of the mitochondrial genome |
Q31167061 | Animal phylogenomics: multiple interspecific genome comparisons |
Q36481133 | Application of oligonucleotide arrays to high-content genetic analysis |
Q36691728 | Arrayed identification of DNA signatures |
Q90571450 | Associations of Peripheral Artery Disease With Calf Skeletal Muscle Mitochondrial DNA Heteroplasmy |
Q37861341 | Automated identification of multiple micro-organisms from resequencing DNA microarrays |
Q37623418 | Biocomplexity and Fractality in the Search of Biomarkers of Aging and Pathology: Focus on Mitochondrial DNA and Alzheimer's Disease |
Q33520448 | Biomarker Validation for Aging: Lessons from mtDNA Heteroplasmy Analyses in Early Cancer Detection. |
Q37148779 | Biomarkers in gastrointestinal cancers |
Q27990522 | Chip-based mtDNA mutation screening enables fast and reliable genetic diagnosis of OXPHOS patients |
Q37112499 | Comparing whole genomes using DNA microarrays |
Q24792059 | Comparisons of substitution, insertion and deletion probes for resequencing and mutational analysis using oligonucleotide microarrays |
Q34238839 | Complete mitochondrial genome sequencing reveals novel haplotypes in a Polynesian population. |
Q27006760 | Composition of the early intestinal microbiota: knowledge, knowledge gaps and the use of high-throughput sequencing to address these gaps |
Q34658510 | Comprehensive association testing of common mitochondrial DNA variation in metabolic disease |
Q34936714 | Contribution of non-reference alleles in mtDNA of Alzheimer's disease patients |
Q45861453 | DNA microarray analysis for the detection of mutations in hemophilia A. |
Q33494042 | Detection of genomic variation by selection of a 9 mb DNA region and high throughput sequencing |
Q36796259 | Detection of mutations in mtDNA. |
Q37653128 | Detection of specific chromosomal aberrations in urine using BCA-1 (oligo-CGH-array) enhances diagnostic sensitivity and predicts the aggressiveness of non-muscle-invasive bladder transitional cell carcinoma |
Q54613942 | Development of a human mitochondria-focused cDNA microarray (hMitChip) and validation in skeletal muscle cells: implications for pharmaco- and mitogenomics. |
Q24802773 | Diagnosis of HNF-1alpha mutations on a PNA zip-code microarray by single base extension |
Q36662396 | Differences in mtDNA haplogroup distribution among 3 Jewish populations alter susceptibility to T2DM complications. |
Q33361663 | Distilling artificial recombinants from large sets of complete mtDNA genomes |
Q28272506 | Effect of mtDNA mutation on tumor malignant degree in patients with prostate cancer |
Q33548726 | Empirical evaluation of oligonucleotide probe selection for DNA microarrays |
Q39256165 | Erythrocytosis in hepatocellular carcinoma portends poor prognosis by respiratory dysfunction secondary to mitochondrial DNA mutations |
Q44783293 | Extensive and rapid screening for major mitochondrial DNA point mutations in patients with hereditary hearing loss |
Q54446837 | Extensive screening system using suspension array technology to detect mitochondrial DNA point mutations. |
Q33292683 | External contamination in single cell mtDNA analysis |
Q33327587 | Facile whole mitochondrial genome resequencing from nipple aspirate fluid using MitoChip v2.0. |
Q34645886 | Familial pancreatic cancer: the case for prophylactic pancreatectomy in lieu of serial screening and shared decision making |
Q33491002 | Following mitochondrial footprints through a long mucosal path to lung cancer |
Q24674610 | Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck |
Q51073392 | Full-Length Mitochondrial-DNA Sequencing on the PacBio RSII. |
Q57395946 | GeneChips in Stem Cell Research |
Q40377467 | Genomic alterations in cultured human embryonic stem cells |
Q54443315 | Genotyping mitochondrial DNA single nucleotide polymorphisms by PCR ligase detection reactions. |
Q35222494 | Heteroplasmic mitochondrial DNA mutations in normal and tumour cells |
Q36497083 | High-throughput mutational analysis of the human cancer genome |
Q35595744 | High-throughput retina-array for screening 93 genes involved in inherited retinal dystrophy |
Q53183619 | Highly Ordered Arrays of Femtoliter Surface Droplets. |
Q22252348 | How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models |
Q43223092 | Identification of frequent chromosome copy-number polymorphisms by use of high-resolution single-nucleotide-polymorphism arrays |
Q36328508 | Identifying molecular markers for the early detection of pancreatic neoplasia |
Q24683257 | Impaired FGF signaling contributes to cleft lip and palate |
Q37152683 | Inosine triphosphate pyrophosphohydrolase (ITPA) polymorphic sequence variants in adult hematological malignancy patients and possible association with mitochondrial DNA defects |
Q34051752 | Insights into N-calls of mitochondrial DNA sequencing using MitoChip v2.0. |
Q33300291 | Interspecies hybridization on DNA resequencing microarrays: efficiency of sequence recovery and accuracy of SNP detection in human, ape, and codfish mitochondrial DNA genomes sequenced on a human-specific MitoChip |
Q42182427 | Intraspecific phylogeographic genomics from multiple complete mtDNA genomes in Atlantic cod (Gadus morhua): origins of the "codmother," transatlantic vicariance and midglacial population expansion |
Q41915881 | MITOMASTER: a bioinformatics tool for the analysis of mitochondrial DNA sequences |
Q21145264 | Matrix-assisted laser desorption/ionisation, time-of-flight mass spectrometry in genomics research |
Q36399439 | Microarray technology: beyond transcript profiling and genotype analysis |
Q24805498 | Microarray-based resequencing of multiple Bacillus anthracis isolates |
Q39448724 | Mitochondria and cancer: past, present, and future |
Q36359505 | Mitochondria as a target for early detection and diagnosis of cancer |
Q36366516 | Mitochondrial DNA Mutations in Grade II and III Glioma Cell Lines Are Associated with Significant Mitochondrial Dysfunction and Higher Oxidative Stress |
Q34447747 | Mitochondrial DNA Sequence Variation Associated With Peripheral Nerve Function in the Elderly |
Q35789945 | Mitochondrial DNA as a cancer biomarker |
Q89467884 | Mitochondrial DNA m.13514G>A heteroplasmy is associated with depressive symptoms in the elderly |
Q36557982 | Mitochondrial DNA mutations in human cancer |
Q28247396 | Mitochondrial DNA mutations in pancreatic cancer |
Q35574219 | Mitochondrial DNA mutations in preneoplastic lesions of the gastrointestinal tract: a biomarker for the early detection of cancer |
Q35729786 | Mitochondrial DNA sequence variation and risk of pancreatic cancer |
Q34140769 | Mitochondrial DNA sequence variation associated with dementia and cognitive function in the elderly |
Q30417487 | Mitochondrial DNA sequence variation is associated with free-living activity energy expenditure in the elderly |
Q33443895 | Mitochondrial DNA variants of respiratory complex I that uniquely characterize haplogroup T2 are associated with increased risk of age-related macular degeneration |
Q37260045 | Mitochondrial and nuclear genes of mitochondrial components in cancer |
Q34826613 | Mitochondrial common deletion, a potential biomarker for cancer occurrence, is selected against in cancer background: a meta-analysis of 38 studies |
Q34526536 | Mitochondrial disease genetic diagnostics: optimized whole-exome analysis for all MitoCarta nuclear genes and the mitochondrial genome |
Q36666800 | Mitochondrial disease: maintenance of mitochondrial genome and molecular diagnostics |
Q37618225 | Mitochondrial gene profiling: translational perspectives |
Q38089732 | Mitochondrial genome analysis in biofluids for early cancer detection and monitoring |
Q34051544 | Mitochondrial genome sequence analysis: a custom bioinformatics pipeline substantially improves Affymetrix MitoChip v2.0 call rate and accuracy. |
Q33521198 | Mitochondrial mutations in adenoid cystic carcinoma of the salivary glands |
Q37430656 | Mitochondrial polymorphisms impact outcomes after severe traumatic brain injury |
Q35819374 | Mitochondrial subversion in cancer |
Q33418617 | Mitochondrial variants in schizophrenia, bipolar disorder, and major depressive disorder |
Q34367770 | Mitochondrial-nuclear epistasis: implications for human aging and longevity |
Q28305528 | Mitogenomic and microsatellite variation in descendants of the founder population of Newfoundland: high genetic diversity in an historically isolated population |
Q36064579 | Molecular analysis of pancreatic juice: a helpful tool to differentiate benign and malignant pancreatic tumors? |
Q36485336 | Molecular genetics of pancreatic ductal adenocarcinomas and recent implications for translational efforts |
Q38520403 | Molecular markers in bladder cancer: Novel research frontiers |
Q37081461 | Molecular markers of pancreatic cancer: development and clinical relevance |
Q38703672 | MtDNA As a Cancer Marker: A Finally Closed Chapter? |
Q33318717 | Multiple strand displacement amplification of mitochondrial DNA from clinical samples |
Q34468858 | Next-generation sequencing of human mitochondrial reference genomes uncovers high heteroplasmy frequency |
Q38286089 | Noninvasive approaches for detecting and monitoring bladder cancer |
Q36589155 | Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling |
Q36896536 | Pancreatic cancer screening |
Q33373844 | Performance of mitochondrial DNA mutations detecting early stage cancer |
Q33733649 | Potential pitfalls in MitoChip detected tumor-specific somatic mutations: a call for caution when interpreting patient data |
Q37206617 | Prevalence of rare mitochondrial DNA mutations in mitochondrial disorders |
Q34035565 | Rapid identification of a novel complex I MT-ND3 m.10134C>A mutation in a Leigh syndrome patient |
Q48105064 | Recent Advances in Detecting Mitochondrial DNA Heteroplasmic Variations. |
Q33520355 | ReseqChip: automated integration of multiple local context probe data from the MitoChip array in mitochondrial DNA sequence assembly |
Q36344973 | Sequence-specific nucleic acid detection from binary pore conductance measurement |
Q35790237 | Somatic mitochondrial DNA mutations in prostate cancer and normal appearing adjacent glands in comparison to age-matched prostate samples without malignant histology |
Q24564006 | Strategies for early detection of resectable pancreatic cancer |
Q34411977 | T cell activation markers and African mitochondrial DNA haplogroups among non-Hispanic black participants in AIDS clinical trials group study 384. |
Q36577260 | Technology Insight: querying the genome with microarrays--progress and hope for neurological disease |
Q34039684 | Testicular cancer survivorship: research strategies and recommendations |
Q35718294 | The awakening of an advanced malignant cancer: an insult to the mitochondrial genome |
Q38089243 | The mitochondrial genome: a biosensor for early cancer detection? |
Q28768152 | The pseudo-mitochondrial genome influences mistakes in heteroplasmy interpretation |
Q36944218 | Toward a new era in sequencing |
Q27990530 | Validation of microarray-based resequencing of 93 worldwide mitochondrial genomes |
Q50456640 | Whole mitochondrial genome screening in maternally inherited non-syndromic hearing impairment using a microarray resequencing mitochondrial DNA chip. |
Q42696451 | mit-o-matic: a comprehensive computational pipeline for clinical evaluation of mitochondrial variations from next-generation sequencing datasets |